000 | 01675 a2200493 4500 | ||
---|---|---|---|
005 | 20250513210044.0 | ||
264 | 0 | _c20000630 | |
008 | 200006s 0 0 eng d | ||
022 | _a1015-9770 | ||
024 | 7 |
_a10.1159/000016057 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aTarkowski, E | |
245 | 0 | 0 |
_aIntrathecal release of nitric oxide and its relation to final brain damage in patients with stroke. _h[electronic resource] |
260 |
_bCerebrovascular diseases (Basel, Switzerland) _c |
||
300 |
_a200-6 p. _bdigital |
||
500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
650 | 0 | 4 | _aAdult |
650 | 0 | 4 | _aAged |
650 | 0 | 4 | _aApoptosis |
650 | 0 | 4 |
_aBiomarkers _xcerebrospinal fluid |
650 | 0 | 4 |
_aBrain _xdiagnostic imaging |
650 | 0 | 4 |
_aBrain Damage, Chronic _xdiagnostic imaging |
650 | 0 | 4 |
_aCytokines _xcerebrospinal fluid |
650 | 0 | 4 | _aFemale |
650 | 0 | 4 | _aGas Chromatography-Mass Spectrometry |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 | _aMagnetic Resonance Imaging |
650 | 0 | 4 | _aMale |
650 | 0 | 4 | _aMiddle Aged |
650 | 0 | 4 |
_aNitrates _xcerebrospinal fluid |
650 | 0 | 4 |
_aNitric Oxide _xcerebrospinal fluid |
650 | 0 | 4 | _aReference Values |
650 | 0 | 4 |
_aStroke _xcerebrospinal fluid |
650 | 0 | 4 | _aTime Factors |
650 | 0 | 4 | _aTomography, X-Ray Computed |
650 | 0 | 4 |
_afas Receptor _xcerebrospinal fluid |
700 | 1 | _aRingqvist, A | |
700 | 1 | _aRosengren, L | |
700 | 1 | _aJensen, C | |
700 | 1 | _aEkholm, S | |
700 | 1 | _aWennmalm, A | |
773 | 0 |
_tCerebrovascular diseases (Basel, Switzerland) _gvol. 10 _gno. 3 _gp. 200-6 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1159/000016057 _zAvailable from publisher's website |
999 |
_c10726668 _d10726668 |